Read more
"According to longstanding scientific consensus, vaccines are widely regarded as playing a fundamental role in public health. Therefore, one would reasonably expect that the dynamics of vaccine production and distribution would place a premium on incentivizing robust levels of investment in vaccine development, with the allocation of resulting vaccine occurring in ways that reflect public health priorities. Yet, that is often not the case. This book examines this disjunction from the viewpoint of the laws, policies and other market-driven forces that shape the development and distribution of vaccines. Together, these mechanisms have long led to problems of under-investment in vaccine research and production, and inequitable allocation of limited vaccine supply in ways that recurrently disadvantage lower-income populations"--
List of contents
Introduction; 1. Vaccines as instruments of public health; 2. The vaccine development ecosystem; 3. Vaccine development under proprietary paradigms; 4. Access to vaccine technology; 5. Aligning vaccine innovation with public health needs; 6. Vaccines of the future: present and emerging challenges; Conclusion: broader implications for global public health.
About the author
Ana Santos Rutschman is outgoing Assistant Professor of law Saint Louis University and incoming Professor of Law at Villanova University. She was named a Health Law Scholar (2018) and a Bio Intellectual Property Scholar (2017) by the American Society of Law, Medicine & Ethics for her work on vaccine law and policy.
Summary
Since the pandemic, we have all become more aware of the mechanisms of vaccine development and distribution, and interested in how it could be improved. This book explains the legal and policy issues for a non-specialist readership, covering key problems in vaccine regulation, patents, technology transfer, and international relations.
Foreword
Examines the development and allocation of vaccines against emerging diseases from the viewpoint of technology and innovation policy.
